Commercial antibodies used were as follows: rabbit anti-Akt (C67E7, 4691, Cell Signaling Technology, Danvers, MA), rabbit anti-pAkt S473 (D9E, 4060, Cell Signaling Technology), rabbit anti-Akt1 (C73H10, 2938, Cell Signaling Technology), rabbit anti-Akt2 (5B5, 2964, Cell Signaling Technology), rabbit anti-Akt3 (4059, Cell Signaling Technology), rabbit anti-ERK1/2 (137F5, 4695, Cell Signaling Technology), rabbit anti-pERK1/2 T202/Y204 (D13.14.4E, 4370, Cell Signaling Technology),
rabbit anti-p38 (9212, Cell Signaling Technology), rabbit anti-p-p38 T180/Y182 (D3F9, 4511, Cell Signaling Technology),
rabbit anti-podocin (PO372, Sigma), mouse anti-β-actin (AC15, A1978, Sigma), rabbit anti-cadherin (
ab16505, Abcam, Cambridge, UK), and rabbit anti-ERβ (H-150, SC-8974, Santa Cruz). Rabbit anti-nephrin was described previously.
44 (link)
Phospho-specific anti-nephrin antibodies were generated and validated previously.
45 (link)
All primary antibodies were used at 1:1000 except for podocin and β-actin, which were used at 1:5000. Secondary horseradish peroxidase-conjugated goat anti-mouse (170-6516, BioRad, Hercules, CA) and goat anti-rabbit (170-6515, BioRad) antibodies were used at 1:5000 for immunoblot detection.
Mahesaniya A., Williamson C.R., Keyvani Chahi A., Martin C.E., Mitro A.E., Lu P., New L.A., Watson K.L., Moorehead R.A, & Jones N. (2022). Sex Differences in Glomerular Protein Expression and Effects of Soy-Based Diet on Podocyte Signaling. Canadian Journal of Kidney Health and Disease, 9, 20543581221121636.